royal medical center semaglutide Primary Care Services in Fort Lauderdale and Palm Beach, FL RX Patient Care Hub |

Indications: Type 2 diabetes, CV risk reduction in T2D patients with heart disease Doses: 0.6 mg (starter) 1.2 mg 1.8 mg/day Best for: Patients wanting a daily injectable with strong CV data Rybelsus (Oral Semaglutide Tablet) Rybelsus is the only oral GLP-1 medication currently available

Access this article Similar content being viewed by others Data availability Since it is a review article, there is no data

References Heymsfield, S

Injectable GLP-1 receptor agonists provide predictable absorption of the active drug directly into systemic circulation, resulting in consistent glucose-lowering activity

Choosing the right one depends on your medical goals, insurance coverage, and personal preference